Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bis(5'-adenosyl)-triphosphatase is a hydrolase enzyme that catalyzes the cleavage of nucleoside triphosphate analogs, specifically hydrolyzing A-5'-PPP-5'A (a dinucleoside triphosphate) to AMP and ADP. Its gene, FHIT, is frequently referred to as a tumor suppressor in specific tissues and may have a role in preventing cancer development. The protein binds Nickel cations, operates in the cytoplasm, and is classified functionally as a catalytic enzyme in nucleotide metabolism, with additional possible roles in tumor suppression, though its protein type is sometimes listed as "unknown" in some protein databases[2][8]. There are no current drugs that target this enzyme, and it is not commonly used as a clinical biomarker at this time. Caveats: The name "Bis-triphosphatase" is slightly ambiguous, as it omits the specific substrates; the canonical enzyme is "Bis(5'-adenosyl)-triphosphatase," and broader "bisphosphatase" or "triphosphatase" enzymes can describe different activities (e.g., fructose bisphosphatases in glycolysis, see [3], but these are completely distinct molecular entities)[3][5][7]. The information here is specific to the bis(5'-adenosyl)-triphosphatase and its FHIT gene product, matching standard usage in major biomedical databases[2][8]. If you are seeking information on a non-nucleotide "bis-triphosphatase," such as one involved in central metabolism (e.g., fructose-1,6-bisphosphatase), re-specification would be required. Otherwise, all information maps to the nucleotide hydrolase, bis(5'-adenosyl)-triphosphatase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bis(5'-adenosyl)-triphosphatase.